Product development studies on surface-adsorbed nanoemulsion of olmesartan medoxomil as a capsular dosage form

AAPS PharmSciTech

Volumn 13, Issue 4, 2012, Pages 1212-1221

  Singh, Sumita ^a   Pathak, Kamla ^a   Bali, Vikas ^a  

^a Rajiv Academy for Pharmacy ^*  (India)

Author keywords

bioavailability; nanoemulsion; olmesartan medoxomil; oral

Indexed keywords

EXCIPIENT; MACROGOL 400; OCTANOIN; OIL; OLMESARTAN; POLYSORBATE 80; SILICON DIOXIDE; SURFACTANT; WATER;

ARTICLE; CHEMICAL COMPOSITION; DRUG CAPSULE; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; DRUG STABILITY; GLOBULE SIZE; NANOEMULSION; PHYSICAL PARAMETERS; POLYDISPERSITY INDEX; PRIORITY JOURNAL; PRODUCT DEVELOPMENT; REFRACTION INDEX; SURFACE ADSORBED NANOEMULSION; THERMODYNAMICS; VISCOSITY; ZETA POTENTIAL;

ADSORPTION; CAPSULES; CHEMISTRY, PHARMACEUTICAL; COLLOIDS; DRUG STABILITY; EMULSIONS; EXCIPIENTS; IMIDAZOLES; NANOPARTICLES; OILS; PARTICLE SIZE; SILICON DIOXIDE; SOLUBILITY; SURFACE-ACTIVE AGENTS; TETRAZOLES; VISCOSITY;

EID: 84871654093     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-012-9847-7     Document Type: Article

References (32)

1. Murakamia T, Konnoa H, Fukutsua N, Onoderaa M, Kawasakia T, Kusub F. Identification of a degradation product in stressed tablets of olmesartan medoxomil by the complementary use of HPLC hyphenated techniques. J Pharmaceut Biomed Anal. 2008;47:553-9.
2. Park JH, Chang JS, El-Gamal MI, Choi WK, Lee WS, Chung HJ, et al. Novel amides and esters prodrugs of olmesartan: synthesis, bioconversion, and pharmacokinetic evaluation. Bioorg Med Chem Lett. 2010;20:5895-9.
3. Klaus O, Stumpe MD. Olmesartan compared with other angiotensin II receptor antagonists: head to head trial. Clin Ther. 2004;26:A33-7.
4. Wehling M. Can the pharmacokinetic characteristics of olmesartan medoxomil contribute to the improvement of blood pressure control? Clin Ther. 2004;26:A21-7.
5. Nakagomi-Hagihara R, Nakai D, Kawai K, Yoshigae Y, Tokui T, Abe T. Oatp1b1, Oatp1b3 and Mrp2 are involved in hepatobiliary transport of olmesartan, a novel angiotensin II Blocker. Drug Metabol Dispos. 2006;34:862-9.
6. Matsushima S, Maeda K, Kondo C, Hirano M, Sasaki M, Suzuki H, et al. Identification of the hepatic efflux transporters of organic anions using doubletransfected Madin-Darby canine kidney II cells expressing human organic anion-transporting polypeptide 1B1 (OATP1B1)/multidrug resistanceassociated protein 2, OATP1B1/multidrug resistance 1, and OATP1B1/breast. J Pharmacol Exp Ther. 2005;314:1059-67.
7. Lawrence MJ, Rees GD. Microemulsion-based media as novel drug delivery system. Adv Drug Deliv Rev. 2000;45:89-121.
8. Qian C, McClements DJ. Formation of nanoemulsions stabilized by model food-grade emulsifiers using high-pressure homogenization: factors affecting particle size. Food Hydrocolloids. 2011;25:1000-8.
9. Chen H, Khemtong C, Yang X, Chang X, Gao J. Nanonization strategies for poorly water soluble, drugs. Drug Discov Today. 2011;16:354-60.
10. Shono Y, Nishihara H, Matsuda Y, Furukawa S, Okada N, Fujita T, et al. Modulation of intestinal P-glycoprotein function by cremophor EL and other surfactants by an in vitro diffusion chamber method using the isolated rat intestinal membranes. J Pharm Sci. 2004;93:877-85.
11. Lee BS, Kang MJ, Choi WS, Choi YB, Kim HS, Lee SK, et al. Solubilized formulation of olmesartan medoxomil for enhancing oral bioavailability. Arch Pharm Res. 2009;132:1629-35.
12. Bali V, Ali M, Ali J. Nanocarrier for the enhanced bioavailability of a cardiovascular agent: in vitro, pharmacodynamic, pharmacokinetic and stability assessment. Int J Pharm. 2011;403:46-56.
13. Kohli K, Chopra S, Dhar D, Arora S, Khar RK. Self-emulsifying drug delivery systems: an approach to enhance oral bioavailability. Drug Discov Today. 2010;15:958-65.
14. Vior MCG, Monteagudo E, Dicelio LE, Awruch J. A comparative study of a novel lipophilic phthlocyanine incorporated into NE formulation: photophysics, size, solubility and thermodynamic stability. Dyes Pig. 2011;91:208-14.
15. Mandawgade SD, Sharma S, Pathak S, Patrawale VB. Development of SMEDDS using natural lipophile: application to artemether delivery. Int J Pharm. 2008;362:179-83.
16. Date AA, Nagarsenker MS. Design and evaluation of self nanoemulsifying drug delivery system (SNEDDS) for cefpodoxime proxetil. Int J Pharm. 2007;329:166-72.
17. Patel AR, Vavia PR. Preparation and in vivo evaluation of SMEDDS (self-microemulsifying drug delivery system) containing fenofibrate. AAPS J. 2007;9:E344-52.
18. Nazzal S, Khan MA. Controlled release of a self-emulsifying formulation from a tablet dosage form: stability assessment and optimization of some processing parameters. Int J Pharm. 2006;315:110-21.
19. Sinko PJ. Martin's pharmacy and pharmaceutical sciences. 5th ed. Woltre Kulwer (India) Pvt Ltd.; 2008.
20. Laies P, Puchler K, Kirch W. The pharmacokinetics and metabolic profile of olmesartan medoxomil limits the risk of clinically relevant drug interaction. J Hypertens. 2001;19:S21-32.
21. Shinoda K, Kuneda H. The effect of salt concentration, temperature, and additives on the solvent property of aerosol OT solution. J Colloid Interface Sci. 1987;118:586-9.
22. Shafiq S, Shakeel F, Talegaonkar S, Ahmad FJ, Khar RK, Ali M. Development and bioavailability assessment of ramipril nanoemulsion formulation. Eur J Pharm Biopharm. 2007;66:227-43.
23. Khoo SM, Humberstone AJ, Porter CJH, Edwards GA, Charman WN. Formulation design and bioavailability assessment of lipidic self-emulsifying formulations of halofantrine. Int J Pharm. 1998;167:155-64.
24. Rajpoot P, Bali V, Pathak K. Anticancer efficacy, tissue distribution and blood pharmacokinetics of surface modified nanocarrier containing melphalan. Int J Pharm. 2012;426:219-30.
25. Constanitinides PP, Scalart JP, Lancaster C, Marcello J, Marks G, Ellens H. Formulation and intestinal absorption enhancement evaluation of water-in-oil microemulsions incorporating medium-chain glycerides. Pharm Res. 1994;11:1385-90.
26. Gershanik T, Benzeno S, Benita S. Interaction of the self-emulsifying lipid drug delivery system with mucosa of everted rat intestine as a function of surface charge and droplet size. Pharm Res. 1998;15:863-9.
27. Yoo JH, Shanmugam S, Thapa P, Lee ES, Balakrishnan P, Yoo SK. Novel self-nanoemulsifying drug delivery system for enhanced solubility and dissolution of lutein. Arch Pharm Res. 2010;33:417-26.
28. Gursoy RN, Benita S. Self-emulsifying drug delivery system (SEDDS) for improved oral delivery of lipophilic drugs. Biomed Pharmacother. 2004;58:173-82.
29. Pouton C. Formulation of self-emulsifying drug delivery systems. Adv Drug Deliv Rev. 1997;25:47-58.
30. Row CR, Sheskey PJ, Owe SC. Handbook of pharmaceutical excipients. 5th ed. Royal society of Great Britain; 2006.
31. Aulton ME. The science of dosage form design. 2nd ed. London: Churchill & Livingstone; 2002.
32. Gennaro AR. Remington: the science and practice of pharmacy. 20th ed. Philadelphia: Lippincott Williams & Wilkins; 2004.